Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-31 @ 4:04 AM
Study NCT ID:
NCT07331467
Status:
RECRUITING
Last Update Posted:
2026-01-12
First Post:
2025-12-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE
Sponsor:
Chongqing Precision Biotech Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PBC092
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None